|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation expense | |||||
| Depreciation and amortization expense | |||||
| Non-cash interest associated with the sale of future royalties | |||||
| Non-cash royalty revenue | |||||
| Deferred income taxes | |||||
| Premium paid on marketable securities | |||||
| Amortization (accretion) of premiums (discounts) on marketable securities | |||||
| Loss on disposal of property and equipment | |||||
| Change in fair value of Series 1 nonconvertible preferred stock | |||||
| Other non-cash items | |||||
| Change in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Income tax receivable | |||||
| Operating lease, right-of-use assets | |||||
| Other long-term assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Operating lease liabilities | |||||
| Other long-term liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Purchase of marketable securities | |||||
| Proceeds from maturities and sale of marketable securities | |||||
| Purchase of property and equipment | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities | |||||
| Payments on royalty sale liability, net of imputed interest | |||||
| Proceeds from the exercise of stock options | |||||
| Proceeds from the sale of future royalties | |||||
| Payments for debt issuance costs | |||||
| Payments for settlement of share-based awards | |||||
| Net cash (used in) provided by financing activities | |||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental disclosure of cash flow information | |||||
| Cash paid for taxes | |||||
| Cash paid for interest | |||||
| Cash received from tenant improvement allowances | |||||
| Cash received from income tax refund | |||||
| Supplemental disclosure of non-cash information: | |||||
| Purchases of fixed assets included in accounts payable and accrued expenses | |||||
| Operating lease liabilities arising from obtaining right-of-use assets | |||||
Loading...